Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 8: 50th year of the DMDG
Open access
1,691
Views
1
CrossRef citations to date
0
Altmetric
Reviews
A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies
Vanessa Martinsa Astex Pharmaceuticals, Cambridge, UKCorrespondence[email protected]
https://orcid.org/0000-0003-2127-8338
Lynsey Fazala Astex Pharmaceuticals, Cambridge, UK
, Aram Oganesianb Astex Pharmaceuticals, Pleasanton, CA, USA
, Alpesh Shaha Astex Pharmaceuticals, Cambridge, UK
, Jessie Stowa Astex Pharmaceuticals, Cambridge, UK
, Hugh Waltona Astex Pharmaceuticals, Cambridge, UK
& Nicola Wilshera Astex Pharmaceuticals, Cambridge, UK
https://orcid.org/0000-0001-6638-9715
Pages 786-796
|
Received 10 Aug 2022, Accepted 27 Sep 2022, Published online: 20 Dec 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.